MORGAN STANLEY PLC/PUT/ELEVANCE HEALTH/500/0.01/20.09.24 Share Price

Warrant

DE000ME83M48

Market Closed - Börse Stuttgart 12:28:37 08/06/2024 am IST
0.091 EUR -3.19% Intraday chart for MORGAN STANLEY PLC/PUT/ELEVANCE HEALTH/500/0.01/20.09.24
Current month-18.02%
1 month-14.15%
Date Price Change
07/24/07 0.091 -3.19%
06/24/06 0.094 -1.05%
05/24/05 0.095 +5.56%
04/24/04 0.09 -3.23%
03/24/03 0.093 -16.22%

Delayed Quote Börse Stuttgart

Last update June 08, 2024 at 12:28 am IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ELEVANCE HEALTH, INC.
Issuer Morgan Stanley
WKN ME83M4
ISINDE000ME83M48
Date issued 02/02/2024
Strike 500 $
Maturity 20/09/2024 (104 Days)
Parity 100 : 1
Emission price 0.38
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.32
Lowest since issue 0.076
Delta-0.24x
Omega 12.06
Premium9.23x
Gearing49.9x
Moneyness 0.9277
Difference Strike -38.94 $
Difference Strike %-7.79%
Spread 0.01
Spread %9.52%
Theoretical value 0.1000
Implied Volatility 24.56 %
Total Loss Probability 71.79 %
Intrinsic value 0.000000
Present value 0.1000
Break even 489.20 €
Theta-0.01x
Vega0.01x
Rho-0x

Company Profile

Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.). Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system. At the end of 2023, the group had nearly 47 million medical members.
Sector
-
More about the company

Ratings for Elevance Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Elevance Health, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
538.9 USD
Average target price
607.2 USD
Spread / Average Target
+12.66%
Consensus